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Introduction
Medication prescribing errors are amajor contributor
to preventable iatrogenic injury, causing an estimated
1 million hospitalisations and 7000 deaths annually
and costing the US healthcare system in excess of $500
million annually.1–11 Incomplete or inaccurate infor-
mation about patient medication use represents a
major root cause of errors and, therefore, an important
opportunity for systemic quality improvement.12–15
Informationgaps tend tooccur at interfaces, orhandoﬀs,
in care (e.g. admissions, discharges, ambulatory and
home health visits) secondary to: (1) fragmentation of
record documentation, (2) changes in patient clinical
status, (3) discontinuity in providers, (4) limited patient
functional health literacy and (5) changes in therapy.16–19
For this reason, healthcare quality organisations,
including the Joint Commission (TJC), have called for
the implementation of standardised medication rec-
onciliation (MR) processes to narrow information
gaps at interfaces.20 The four steps required by TJC
forMR include: (1) collection of amedication history,
(2) comparison with existing documentation, (3) resol-
ution of unexplained diﬀerences in medication lists
and (4) communicationwith the patient and the health-
care team.21 Although preliminary research suggests
that MR can identify discrepancies associated with
adverse drug events, healthcare organisations have
struggled to identify the most eﬀective implementation
strategies.5,19,22,23 Many teams use pharmacists and
pill clinics, but this can be resource prohibitive.7,24–28
Hence, developers have experimented with health infor-
mation technology (HIT) to capture patient self-entered
medication adherence information.14,15,17,19,22,29–34
Setting
ThePortlandVeteransAﬀairsMedical Center (PVAMC)
is one of 156 US federally supported and managed
tertiary care faciilities delivering care to an estimated 8
million former military personnel. The Portland PC
division manages an estimated 40 000 veterans across
nine clinic locations located in the Paciﬁc Northwest
USA and completes an estimated 84 000 outpatient
visits per year. The average patient is 60.8 years old and
takes an average of eight medications.
All VA providers use the Computerized Patient
Record System (CPRS) to enter orders and view patient
information stored in the VA database. The VA phar-
macy service supports the entire medication supply
chain. Providers enter electronic prescriptions and
pharmacists ﬁll and dispense medications from local
ABSTRACT
Background Although medication reconciliation
(MR) can reduce medication discrepancies, it is
challenging to operationalise. Consequently, we
developed a health information technology (HIT)
to collect a patient medication history and make it
available to the primary care (PC) provider. We
deployed a self-service kiosk in a PC clinic that
permits patients to indicate amedication adherence
history. Patient responses are immediately viewable
in the legacy electronic health record. This paper
describes a survey developed to assess PC provider
perceptions of our HIT and HIT implementation
eﬀectiveness.
Methods We developed and administered a survey
to all PC providers to assess technology implemen-
tation eﬀectiveness. The survey included scales meas-
uring (1) user attitudes towards MR, (2) perceptions
of our HIT and (3) the local organisational climate
for implementation. We also assessed the consist-
ency and quality of tool use.
Results Nearly 90% of PC providers responded to
the survey and 58% indicated that they were familiar
with the technology and had seen the tool output.
Most providers believed that MR represented an
important safety intervention, although 43% did
not believe that they had the necessary resources to
manage discrepancies. Composite scale scores for
the 58% of respondents familiar with the HIT
indicate that the majority favoured our tool over
usual care. However, composite scale scores suggest
that the climate for implementation at our facility
was suboptimal. Overall, the quality and consist-
ency of tool use among providers was very hetero-
geneous.
Conclusions A patient self-service kiosk oﬀers an
eﬃcientmechanismtocollect amedicationadherence
history; provider survey responses indicate that
they appreciated and used the MR kiosk output.
Nonetheless, opportunities exist to improve data
displays and embed decision support to facilitate
discrepancy management.
Keywords: adverse drug events, biomedical tech-
nology assessment, computerised medical records
systems, consumer health information, medication
errors, medication reconciliation, patient portal,
self-service kiosk (non-MeSH), user–computer inter-
face
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or regional inventories. All medication transactions
are archived in the VA database.
The Portland Veterans Aﬀairs Medical Center
(PVAMC) piloted locally developed HIT and new busi-
ness processes to collect a patient self-entered medi-
cation-adherence history in advance of a primary care
(PC) clinic visit.32Although the technology is universally
available to PVAMC PC staﬀ and patients, use stat-
istics and anecdotal feedback from staﬀ suggest that
technology adoption is heterogeneous. Therefore, we
sought to understand how PC providers are using the
technology and identify facilitators and barriers to
staﬀ adoption. This paper describes the development,
administration and ﬁndings of a survey intended to
assess PC provider perceptions of the tool in an eﬀort
to identify factors that can inﬂuence implementation.
Methods
Literature review
Although there are few published reports exploring
MR perceptions or MR technology usability, there is
a large canon of literature about diﬀusion of inno-
vations and factors inﬂuencing adoption of HIT.35–42
Roger’s diﬀusion of innovation (DOI) theory and
Davis’ technology acceptance model (TAM) provide
theoretical frameworks for describing determinants of
innovation adoption.35,37 Ammenwerth’s ﬁt between
individual, technology and task (FITT) model and
Callen’s contextual implementation model (CIM)
extend this work by developing schematics to analyse
HIT implementations.41,43 We used these models to
identify predictors of implementation eﬀectiveness,
deﬁned as ‘the skillful and consistent use of an inno-
vation by targeted users’.44 Our research focused upon
providers’ perceptions of our MR technology and the
organisational climate for implementation.
Research suggests that user perceptions of three
technology characteristics – ease of technology use,
relative advantage to complete tasks and compatibility
with existing workﬂow processes – are consistently
associated with adoption and use decisions.45–47 Re-
search also suggests that the organisational climate for
implementation is a key determinant of implemen-
tation eﬀectiveness.48,49 The organisation’s climate
for implementation reﬂects the extent to which the
targeted users perceive the organisation to expect,
support and reward technology use. For example, a
strong climate may be cultivated by ensuring that
users acquire skill in technology use, removing ob-
stacles to use and rewarding use of the technology.
Description of technology
In 2006, the Portland Informatics Center (PIC) at the
PVAMC developed a novel medication history collec-
tion technology that interfaces with the legacy elec-
tronic health record (EHR).22,32 The PIC created a
self-service kiosk that enables patients to check-in for a
clinic appointment and review all prescriptions recorded
in the EHR.32 The kiosk shows each prescription on-
screen with a medication photograph to help with
identiﬁcation and recall (Figure 1). The patient uses
website-like touch-screen buttons to indicate adher-
ence patterns. The software then inserts the medi-
cation list and patient responses into the EHR as a text
note for clinician review during the appointment
(Figure 2). We believed that this technical approach
would appeal to clinical staﬀ because: (1) the program
assembles a composite list ofmedications from several
electronic sources more quickly than would a staﬀ
member, (2) the program uses visual prompts to aid
patient recall, (3) transactions are completed before
the clinic appointment and (4) the program automat-
ically charts patient responses in the EHR.50–53
The PIC piloted the kiosk in 2007 and later, with the
consent of executive leadership,made it available in all
clinics. In 2008, we installed kiosks in seven PVAMC
PC clinics, using patient throughput estimations to
determine the number of terminals required.51 The PIC
delivered several presentations to staﬀ and distributed
printed materials in clinic. Since that time, over 250 000
encounters have been completed using the kiosk.
Although we are in the process of cataloging dis-
crepancy types commonly identiﬁed using this tech-
nology, they fall into several main categories often
cited in the literature including:
. omissions, a lack of documentation formedications
patients are currently taking (e.g. patients taking
over-the-counter analgesics or using expired medi-
cations such as sublingual nitroglycerin)
. commissions, erroneous medication entries (e.g.
prescribers neglecting to discontinue medications
that patients report they are no longer taking, citing
lack of beneﬁt, such as gabapentin)
. dose errors, variance between the dose documented
and the dose taken (e.g. inability of the provider to
capture a dynamic dose titration of a drug such as
insulin or prednisone).
The kiosk represents one of two pathways to manage
patient arrivals; clinic staﬀmay instead check-in patients
using the EHR, bypassing the MR tool. Thus, the PIC
tracks the proportion of PC encounters using the
kiosk and the proportion of encounter notes using
the documented output. Although over 90% of patients
can use the kiosk, actual use averages 50% of all
encounters and output is documented in 70% of
kiosk-mediated encounters.32,54
BJ Lesselroth, PJ Holahan, K Adams et al108
Survey development
We developed a survey to measure PVAMC primary
care providers’ perceptions of our tool output (i.e. ease
of use, relative advantage, compatibilitywithworkﬂow),
implementation climate and implementation eﬀec-
tiveness (Table 1) using a three-stage process. First, we
developed a draft survey using previously published
scales adapted to the primary care context.55–58 Sec-
ond, we piloted the draft survey with a group of three
PC providers familiar with the practice setting. We
asked the participants about wording, formatting,
potential for bias and notable omissions in content.
As a result of this review, it became clear that a
provider’s attitude toward patient-centred care and
MR itself might also inﬂuence their decision to adopt
our HIT. We could not locate published scales measur-
ing provider attitudes toward MR or patient-centred
care, so we used several related source materials to
generate items for these scales.18,59,60 We then piloted
the ﬁnal survey with a group of PC providers to ensure
they could complete the survey in less than 10 minutes.
We organised the survey into three sections. The
ﬁrst consisted of a cover page outlining the purpose of
the study, describing the technology and providing
instructions for completion. The second part consisted
of our provider attitudes scales, technology percep-
tions scales (i.e. ease of use, relative advantage, com-
patibility with workﬂow), implementation climate
scale and implementation eﬀectiveness assessment (see
Table 1 for construct deﬁnitions and Appendix 1 for
scale items). The third part of the survey collected
demographic information including age, gender, years
in practice and clinic location.We included a discrimi-
nating question asking providers if they were familiar
with the tool and had seen the tool output. Providers
that were unfamiliar with the technology or had not
seen the output only completed the two attitude scales
and the demographic information.
With one exception, we measured respondent con-
cordance with the survey items using ﬁve-point Likert-
type scales anchored by 5 = ‘strongly agree’ and 1 =
‘strongly disagree’.Wemeasured implementation eﬀect-
iveness as both the quality with which providers used
the tool and the consistency with which they used it.
We assessed quality of tool use by asking respondents
to indicate how they used the tool (i.e. which of 10
tasks they executedwhenusing the tool – seeAppendix
1). Using amethod reported byHolahan and colleagues,
three clinical subject matter experts assigned a weight
to each task according to three criteria: (1) extent of
initiative required, (2) complexity of activity and
Figure 1 Schematic of the medication history collection kiosk architecture with screenshots of the patient-
facing and provider-facing views. The kiosk interface code, business logic and pharmaceutical image
repository are currently stored on a server hosted by facility local area network
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(3) degree of patient or colleague engagement.53 The
weights varied from 3 to 9 and corresponded to the
quality or complexity of care represented by the speciﬁc
task. For example, using the tool to identify discrep-
ancies between clinic records and patient self-report, a
rather rote use of the tool, was assigned a weight of 4,
whereas using the tool to co-ordinate cross-disciplinary
care was assigned a weight of 9. By summing the
weighted scores to the 10 items, we were able to assess
the quality of provider tool use.We assessed consistency
of tool use by asking repondents, ‘Which term best
describes how often you review the tool output when
available during clinic?’ The respondents answered
using a ﬁve-point Likert-type scale anchored by 5 =
‘always’ and 1 = ‘never’. We computed implementation
eﬀectiveness by ﬁrst standardising the respondent’s
scores for consistency of use and quality of use, and
then summing the standardised means.
Survey distribution methods
We surveyed PC providers aﬃliated with PVAMC
clinics between October 2010 and November 2010. A
member of the investigation team administered
surveys during staﬀmeetings and resident educational
sessions. In addition, we left surveys at each clinic for
providers that were not in attendance. All staﬀ and
resident surveys were anonymous, precluding any
attempts to follow-up with non-respondents. How-
ever, we were able to measure the proportion of non-
responders per clinic location. The PVAMC Research
AssuranceOﬃcer reviewed and approved this study as
a quality improvement investigation, exempt from
Institutional Review Board monitoring.
Data analysis
Data analysis included two steps: (1) scale reliability
assessment and (2) results interpretation. All scales
had acceptable reliability scores with the exception of
the ‘patient-centred care’ subscale. Coeﬃcient alpha
for the scale measuring attitudes toward patient-
Table 1 Survey scales and deﬁnitions
Variable Scale Subscale Deﬁnitions
Independent Provider attitudes
toward
Patient-centred care Attitudes towards concordance in patient
medication use, appreciation for patient
values, personal preferences and context
Medication
reconciliation
Extent that clinicians value the role of
medication reconciliation and believe it
contributes to quality of care
Technology
perceptions
Ease of use Ease in learning and eﬃciency in using an
innovation to accomplish tasks
Workﬂow
compatibility
Extent that an innovation integrates or
complements existing work processes
Relative advantage Degree an innovation is perceived as
providing an advantage over technology it
supersedes
Climate for
implementation
Leadership culture Extent to which users perceive organisational
leaders to expect, support and reward the use
of an innovation
Logistics and resources Extent to which users perceive that use of an
innovation is expected and supported
Dependent Implementation
eﬀectiveness
Quality of use Demonstrated skill using an innovation,
extent of initiative shown by the user and
degree that use advances core tasks
Consistency of use The frequency of innovation use
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centred care was 0.35, considerably lower than the 0.70
threshold generally accepted for reliability.61 Despite
use of item analysis and data reduction techniques, we
were unable to demonstrate reliability and removed
this scale from further analysis.
We interpreted survey responses at the scale (con-
struct) and item levels. We computed scale means
for attitude toward MR, technology perceptions and
implementation climate using simple averaging of
the scale items. We scored the quality of use scale by
calculating the sum of each positive response to the
weighted items. We calculated correlation coeﬃcients
to estimate the inﬂuence of the independent variables
on implementation eﬀectiveness, our dependent vari-
able. We compared categorical data using Fisher’s exact
tests and continuous data using t-tests. We then
reconvened two separate groups of PC providers to
review the survey results and provide feedback about
recorded responses.
Results
Ninety-one respondents (55 staﬀ, 30 residents, six
unidentiﬁed) completed the survey, representing 89%
of all PC providers (95% staﬀ, 68% residents) (Table 2).
Of these 91 respondents, 38 (42%) indicated that they
were unfamiliar with the technology and only furnished
demographic andattitude towardMRdata. The remain-
ing 53 respondents indicated that they were familiar
with the technology and completed the survey in its
entirety.
We compared providers reporting familiarity with
the tool with those without knowledge of the tech-
nology. Tests of the diﬀerence inmeans did not demon-
strate any diﬀerences in respondents with respect to
age, gender, years in practice or attitude toward MR.
We did not detect any diﬀerences in the response rate
of staﬀ providers as a function of practice location.
Thus, we concluded that the 53 providers included in
the data analyses were representative of the larger
provider population.
Coeﬃcient alpha, descriptive statistics and corre-
lations between the independent and dependent vari-
able are shown in Table 3. All correlations between the
independent variables (attitude toward MR, technology
perceptions and implementation climate) and the
dependent variable (implementation eﬀectiveness) were
positive and signiﬁcant (P< 0.05), indicating favour-
able attitudes toward MR, favourable perceptions of
the technology, and strong implementation climates
are associated with greater implementation eﬀective-
ness.
Table 2 Characteristics of survey respondents. Note that not all participants answered all
questions
Respondent type
Staﬀ physicians
n (%)
Residents
n (%)
Unknown
n (%)
Total
n (%)
Respondents 55 (60.4) 30 (33.0) 6 (6.6) 91
Age (years)
22–34 6 (6.6) 27 (29.7) 33 (36.3)
35–44 12 (13.2) 2 (2.2) 2 (2.2) 16 (17.6)
45–54 19 (20.9) 1 (1.1) 20 (22.0)
55–64 13 (14.3) 0 1 (1.1) 14 (15.4)
65+ 2 (2.2) 0 2 (2.2)
Missing 6 (6.6) 6 (6.6)
Gender
Male 26 (28.6) 13 (14.3) 4 (4.4) 43 (47.3)
Female 26 (28.6) 17 (18.7) 43 (47.3)
Missing 5 (5.5) 5 (5.5)
Experience with tool
Yes 35 (35.8) 15 (16.5) 3 (3.3) 53 (58.2)
No 19 (20.9) 15 (16.5) 1 (1.1) 35 (38.5)
Missing 3 (3.3) 3 (3.3)
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Individual item responses and mean scores for
scales are shown in Figure 3. Providers held favourable
attitudes towardMR (MRmean score 3.63).However,
it is noteworthy that 43% of providers disagreed with
the statement ‘I have the resources that I need to
address identiﬁed medication discrepancies’.
Perceptions of the technology among respondents
familiar with the tool were generally positive (mean
score 3.12), however, responses to individual items
indicate that although perceptions of the tool’s rela-
tive advantagewere favourable, limitationswere noted
with respect to ease of use and workﬂow compati-
bility. For example, 55% of providers agreed with the
statement ‘The advantages of using [the technology]
for reconciliation outweigh the disadvantages’, whereas
only 18% disagreed. Similarly, 57% of respondents
agreed with the statement ‘using [the technology]
improves the quality of my medication reconciliation
process’, whereas only 20% disagreed. Nevertheless,
35% believed ‘Using [the technology] for MR takes a
lot of mental eﬀort’ and 39% thought work schedules
did not easily accommodate routine use of the tool
output. The scale mean for ‘implementation climate’
was 2.87, indicating a weak climate for implemen-
Table 3 Coeﬃcient alpha, descriptive statistics and correlation coeﬃcients for scales
Evaluation domain No. of items Coeﬃcient

Mean (SD) Range Correlation with
implementation
eﬀectiveness
Attitude toward
MR
7 0.85 3.63 (0.78) (1.00–4.86) 0.37*
Technology
perceptions
15 0.90 3.12 (0.58) (1.68–4.36) 0.63**
Climate for
implementation
4 0.68 2.87 (0.52) (1.50–4.50) 0.51**
Consistency of use 1 na 3.67 (1.12) (1.00–5.00)
Quality of use 10 na 42.12 (18.55) (0–65)
Implementation
eﬀectiveness
na 0.08 (1.74) (–3.75–2.42)
*P<0.05; ** P<0.01, na, not applicable.
Figure 2 Detail of the provider-facing text output inserted by the kiosk software into the legacy electronic
health record. Patient responses and prescription data are integrated into a single list that may be viewed
using the chart notes function
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tation. Nearly half of the providers with familiarity
with the tool did not believe that new clinical staﬀ
received information about the technology and 39%
did not believe there were any incentives to using the
output.
Table 3 includes mean scores for ‘consistency of
use’, ‘quality of use’ and ‘implementation eﬀective-
ness’. There was no pattern evident for ‘quality of use’
item scores as a function of task complexity (Figure 3).
Providers most often used the EHR output to engage
in a dialog with patients, identify discrepancies in clinic
documentation, and satisfy organisational documen-
tation expectations.
Figure 3 Responses and scores for survey items and scales. Lighter grey bars represent a more favourable
response or a greater frequency of use. (* To permit plotting of data in the same direction,we rephrased item
labels referencing reversed scored survey questions listed in Appendix 1.)
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Discussion
Principal ﬁndings
In general, providers believed thatMRwas an import-
ant safety intervention and that our tool improved
their ability to complete requisite tasks. However,
scale and item scores suggest that there are oppor-
tunities to improve technology design and implemen-
tation. First, many providers said the tool output was
challenging to cognitively process and discrepancies
were diﬃcult to identify. We suspect that these prob-
lems are, in part, a function of our data presentation
strategy (Figure 2). Using the existing EHR notes inter-
face to communicate output compromised our ability
to provide decision support or integrate actionable
tools. Second, implementation climate scores suggest
that our organisational culture may impede tech-
nology adoption. Although further study is required,
we suspect several actions could improve adoption,
including provision of recurring informational sessions,
a clear endorsement from executive leadership and
alignment of technology use with staﬀ performance
incentives. Finally, the quality-of-use scales suggest
that providers might beneﬁt from at-the-elbow train-
ing, embedded decision support or EHR enhance-
ments to increase conversion of information into
targeted interventions such as prescription updates,
interdisciplinary messaging and patient education.
Implications of the ﬁndings
Although this study represents a small pilot, there are
some important lessons that may apply to other MR
quality improvement initiatives. First, because MR
tasks are cognitively complex and time intensive,
design interfaces must help providers recognise,
contextualise and manage medication discrepancies;
errors must be categorised, prioritised and linked to
management pathways.1,14,18,19,22,31,34,48 Second, MR
tool implementation success is mediated not just by
attributes of the technology, but also by the extent of
alignment with user values, organisational incentives
and group culture.14,19,33,34,41 Only 55% of providers
agreed that ‘A provider’s time is well spent with the
patient updating the patient medication list’. This
ﬁnding may reveal scepticism over MR’s clinical
impact, reluctance to assume new tasks, apprehension
over the increasedworkload, or a sense of futility given
the inherent challenges of MR.14,18,22
Comparison with the literature
Although, to our knowledge, this is one of the ﬁrst
user-centred evaluations of anMR technology, our ﬁnd-
ings correspond with other published studies explor-
ing the barriers to MR and MR technologies.1,14,17–
19,30,31,34 Socio-organisational barriers previously
attributed to poor MR adoption include limited
time availability, competing resource demands and
poor patient health literacy.6,18,23,25,49,62–64 For
example, Clay and colleagues reported that 16% of
hospitalists did not think MR was worth the eﬀort of
implementation, 50% thought MR was too time
consuming and 87% had diﬃculty gathering reliable
information from the patient.18 Similarly, 16% of our
respondents did not believe a patient’s time with the
doctor was well spent reviewing medications and 77%
of PC providers did not consider patients a reliable
information source about medication adherence.
Our results also mirror many of the technical
barriers to MR cited in the literature, including poor
organisation of pharmaceutical information.1,15,19,25,34
Clinicians typically work with inchoate medication
lists, spending time reorganising information and
struggling with the sheer volume of discrepancies
detected.15,19,23,29,48,65 Previous studies indicate that
providers often feel ill-equipped to manage the vol-
ume ofmedication errors, particularly formedications
outside their scope of practice.22,33 It is, therefore,
incumbent upon implementation specialists to help
clinicians navigate this terrain by providing inter-
departmental policies and pharmacy consultative ser-
vices. Further, PC providers need decision support
systems informed by user-centred design to preserve
medication list context across displays and to support
discrepancy management.1,14,19,22,24,66
Limitations
There are several important limitations to this study.
First, we surveyed PC providers associated with a
single facility, limiting the generalisability of our ﬁnd-
ings. Second, we studied a single MR tool that was
locally developed, requires multi-user co-ordination
and leverages the legacy EHR presentation layer. Hence,
many device attributes are unique and may not apply
to other MR implementations. Third, our kiosk has
only been used by US military veterans. It is possible
that veterans are less adherent to medications because
they take a greater number than typically reported in
the literature (8–12 per person) and discrepancy
detection rates may be higher in the VA than the
private sector.67 However, discrepancy detection may
be inﬂuenced by the availability of electronic prescrip-
tion data. Limited research suggests that there are few
diﬀerences in medication adherence rates when directly
comparing veteran and civilian patients with EHRs.48
Finally, our implementation climate scale alpha was
lower than expected. The scale may need to be adjusted
and validated to accommodate the unique character-
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istics of the VA’s highly distributed organisational
hierarchy.
Call for further research
This paper draws attention to important gaps in MR
knowledge and opportunities for further study. First,
as the medical home movement progresses and sys-
tems embrace a more holistic interpretation of MR, it
will be crucial to measure organisational culture.68
The apparent distrust of patient-furnished information
and lack of enthusiasm for encounter-based medica-
tion review raises concern that providers may favour
clinic records over interviews when compiling amedi-
cation list, despite ample evidence showing that clinic
medication lists are frequently inaccurate.23,25,27,34,66,67,69,70
To this end, we need instruments that measure pro-
vider attitudes towards patient-centred care, shared
decision making and MR. In addition, quality im-
provement specialists need qualitative research to
completely understand deeply embedded and self-
reinforcing beliefs that might undermine MR inter-
ventions.14,71 Second, cognitive studies of MR activities
would oﬀer insight into the mental models, heuristics
and technical requirements necessary to develop
interfaces that support situational awareness, prob-
lem-representation and best-practice care.72,73 Finally,
there is only limited evidence showing that the MR
improves the accuracy of ambulatory medication lists
or signiﬁcantly reduces adverse drug events.8,23,26
Additional well-designed studies are needed demon-
strating the association between speciﬁc interventions
and clinical outcomes to inform system-based im-
provements and galvanise clinician buy-in.
Conclusions
Our preliminary assessment of a novel MR tool
suggests that patient self-directed technology can
eﬃciently gather a medication adherence history for
the PC provider. Thoughtful integration of infor-
mation output into extant work processes can both
increase discrepancy awareness and support reconcili-
ation eﬀorts. This data notwithstanding, the cognitive
overhead and workload associated with MR is substan-
tial, necessitating the development of data displays
that enable discrepancy detection, triage andmanage-
ment. Also, implementation success is, in part, depen-
dent upon a coherent organsational plan, proper
framing of expectations, and allied care resource
allocation. Attention to these issues will be critical as
multimedia and patient-directed point-of-care tech-
nologies begin to occupy a prominent position in the
evolving landscape of healthcare delivery. We hope
that our ﬁndings will inform not only better MR inter-
ventions, but also the design of technologies that
engage patients, enabling them to interact with the
healthcare team on demand and in a greater variety of
settings.
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Appendix 1
Survey items
1. Attitude Toward Medication Reconciliation (scale: 1 = strongly disagree; 5 = strongly agree)
(a) Reconciling medications during clinic is an important way to improve medication safety.
(b) It is valuable for the patient to complete a medication history at each clinic visit.
(c) Reconciling medication lists with the patient is an important way to improve medication adherence.
(d)A provider’s time is well spent with the patient updating the patient medication list.
(e) The primary care provider should take responsibility for reconciling all medications.
(f) I cannot assume responsibility for reconciling medications that other providers prescribe. (RS)
(g) I have the resources that I need to address identiﬁed medication discrepancies.
2. Please check the statement that best describes how familiar you are with [the technology].
3. Technology Perceptions (scale: 1 = strongly disagree; 5 = strongly agree)
Ease of Use
(a) Using [the technology] for medication reconciliation requires a lot of mental eﬀort. (RS)
(b)Overall, I believe that the [technology] output is easy to interpret.
(c) When using [the technology], it is diﬃcult to identify important medication discrepancies. (RS)
Workﬂow Compatibility
(a) The system for supporting medication reconciliation ﬁts into my workﬂow.
(b) Using [the technology] for medication reconciliation makes me do extra work that I did not have previously.
(RS)
(c) Using [the technology] for medication reconciliationmakes me take onmore responsibilities that I did not
have previously. (RS)
(d)Work schedules seem too tight to integrate the routine use of [the technology] into my clinic. (RS)
Relative Advantage
(a) Using [the technology] enables me to review medications quickly.
(b)Using [the technology] improves the quality of my medication reconciliation process.
(c) The advantages of using [the technology] for reconciliation tasks outweigh the disadvantages.
(d) I do not trust information provided by patients through [the technology]. (RS)
(e) Using [the technology] for medication reconciliation is more eﬃcient than other methods.
(f) Using [the technology] for medication reconciliation introduces more errors. (RS)
(g) The information generated by [the technology] is not as accurate as the process I usually use to collect a
medication history. (RS)
4. Climate for Implementation (scale: 1 = strongly disagree; 5 = strongly agree)
(a) A specialist is available to help with the use of [the technology].
(b)When encountering obstacles to using [the technology], our clinician leadership has acted to remove these
obstacles.
(c) In our facility, providers are encouraged to use [the technology] for medication reconciliation.
(d) In our facility, there are no incentives for using [the technology]. (RS)
BJ Lesselroth, PJ Holahan, K Adams et al118
5. Consistency of Use (scale: 1 = never; 5 = always)
(a) Which [number] best describes how often you review the [tool] output when available during clinic?
6. Quality of Tool Use (scale: 1 = never; 3 = always)
(a) I use [the technology] to understand patients’ medication adherence.
(b) I use [the technology] to identify medication discrepancies between VA records and patient self-report.
(c) I use [the technology] output to identify interruptions or delays in medication reﬁlls.
(d) I update medication orders based on information gathered using [the technology].
(e) I update medical record documentation based on information gathered using [the technology].
(f) I use [the technology] output to help satisfy medication reconciliation documentation.
(g) I annotate [the technology] output based on patient feedback.
(h) I ask patients about their medications based on ﬁndings documented in [the technology] output.
(i) I notify other providers of unexpected medication issues identiﬁed while using [the technology].
(j) I engage the assistance of other providers or arrange additional services to address concerns identiﬁed using
[the technology].
7. Demographic Data
(a) Please indicate your primary clinic location.
(b) Please identify the position that best deﬁnes your role.
(c) What is your age?
(d)What is your gender?
(e) How many years have you been in practice?
RS = reverse scored item
